FDA developing QbD examples to ready generic industry for 2013 deadline

By Nick Taylor

- Last updated on GMT

Related tags: Food and drug administration

The US FDA is publishing immediate and modified release QbD examples to help generics companies prepare for full implementation in 2013.

Adoption of question-based review by the US Food and Drug Administration (FDA) moved generics applications towards quality-by-design (QbD). The FDA is now accelerating the QbD push and says it is collaborating with the generics industry to prepare companies for the shift.

We’re working together to develop examples for immediate release dosage forms, as well as for modified release​”, Lawrence Yu, deputy director, science and chemistry at the FDA, told in-PharmaTechnologist. The examples are designed to help generics companies fully adopt QbD.

Manufacturers of generics have until January 2013 to understand and adopt QbD. “As we’ve said many, many times FDA Office of Generic Drugs expects QbD applications starting January 2013. You heard right, full implementation of QbD in January 2013​”, Yu said.

Related news

Show more

Related products

show more

A Culture of Innovation as a Differentiation

A Culture of Innovation as a Differentiation

Softigel by Procaps | 06-Dec-2021 | Product Presentation

We create safe, effective and differentiated pharmaceutical solutions and this has been our goal since day 1. The main driver of our growth is innovation...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Follow us


View more